Copyright
©The Author(s) 2023.
World J Exp Med. Sep 20, 2023; 13(4): 75-94
Published online Sep 20, 2023. doi: 10.5493/wjem.v13.i4.75
Published online Sep 20, 2023. doi: 10.5493/wjem.v13.i4.75
Figure 9 Protein expression of cytokeratin-19/CD45/endothelial growth factor in circulating neural cells in the blood stream of an apparently healthy individual under mediation with light music.
A: The circulating neural cells (CNCs), conjugated with fluorescein isothiocyanate for cytokeratin 19 (CK19); B: Same image with Cy5 for endothelial growth factor (EGF); presenting less cells expressing than CK19; C: Same image with R-phycoerythrin for CD45, and expressing less than CK19; D: Co-expression of dapi/CK19/EGF/CD45. The arrow refers to the CNCs cells with remarkable expression. Presence of CNCs was confirmed by the mode of cytokeratin 19+/CD45.
- Citation: Mehdipour P, Fathi N, Nosratabadi M. Personalized clinical managements through exploring circulating neural cells and electroencephalography. World J Exp Med 2023; 13(4): 75-94
- URL: https://www.wjgnet.com/2220-315X/full/v13/i4/75.htm
- DOI: https://dx.doi.org/10.5493/wjem.v13.i4.75